Abbott Laboratories

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 11:35:34 2024-04-16 am EDT 5-day change 1st Jan Change
109.5 USD +0.56% Intraday chart for Abbott Laboratories -2.75% -0.65%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Equity Futures Gain Pre-Bell Ahead of Busy Earnings Week; Asia Down, Europe Rises MT
S&P 500 Posts Second Consecutive Weekly Drop Led by Financials Amid Higher-Than-Expected Consumer Prices MT
Citigroup Raises Price Target on Abbott Laboratories to $128 From $126, Keeps Buy Rating MT
Abbott's heart valve repair device gets US approval RE
Abbott Laboratories' TriClip Receives FDA Approval for Tricuspid Valve Repair MT
Abbott Gets FDA Approval for TriClip Heart Valve Repair System DJ
US FDA approves Abbott's heart valve repair device RE
Abbott Receives FDA Approval for Triclip?, First-Of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve CI
Abbott Laboratories Says Its i-STAT TBI Cartridge Received US FDA Clearance for Use With Whole Blood MT
Abbott Laboratories Cartridge Gets FDA Clearance to be Used with Whole Blood DJ
Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside CI
Abbott Laboratories' Assert-IQ Insertable Cardiac Monitor Gets CE Mark in Europe MT
Abbott Advances Chronic Pain Management with Small Implanted, Rechargeable Spinal Cord Stimulation System CI
Reckitt shares sink as investors see more trouble from baby formula lawsuits RE
Reckitt unit hit with $60 million verdict in Enfamil baby formula case in Illinois RE
Walgreens settles New York charges it grossly inflated prices of infant formula RE
Abbott Laboratories Recalling HeartMate Touch Communication System MT
Abbott Laboratories Says Real-World Data Show GLP-1 Medicines With FreeStyle Libre Help Manage Type 2 Diabetes MT
Abbott Announces Real-World Data Show Freestyle Libre Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes CI
AbbVie CEO to Retire; COO Robert Michael Named Successor MT
AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO DJ
Abbott Laboratories Maintains Quarterly Dividend at $0.55 a Share, Payable May 15 to Holders of Record April 15. MT
Abbott Declares Quarterly Cash Dividend, Payable on May 15, 2024 CI
Abbott Laboratories Says FDA Advisory Committee Backs TriClip System for Treatment of Tricuspid Regurgitation MT
Correction to Abbott Laboratories Article DJ
Chart Abbott Laboratories
More charts
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
108.9 USD
Average target price
126.4 USD
Spread / Average Target
+16.06%
Consensus
  1. Stock Market
  2. Equities
  3. ABT Stock
  4. News Abbott Laboratories
  5. US to Require Insurers to Pay for At-Home COVID-19 Tests